Cargando…
Study on the treatment of postmenopausal osteoporosis with quercetin in Liuwei Dihuang Pill based on network pharmacology
BACKGROUND: Liuwei Dihuang Pill (LP) was verified to alleviate postmenopausal osteoporosis (PMOP) development. Nevertheless, the major constituent of LP and the related network pharmacology study remain unexplored. METHODS: Protein–protein interaction was established to identify the downstream targe...
Autores principales: | Zhu, Fuping, Li, Wuping, Wang, Linhua, Dai, Bing, Liu, Zongyi, Wu, Hang, Deng, Ting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827666/ https://www.ncbi.nlm.nih.gov/pubmed/36624462 http://dx.doi.org/10.1186/s13018-022-03470-1 |
Ejemplares similares
-
Mechanism of Liuwei Dihuang Pills in treating osteoporosis based on network pharmacology
por: Wang, Xiqoqiang, et al.
Publicado: (2023) -
Network pharmacology-based strategy to investigate pharmacological mechanism of Liuwei Dihuang Pill against postmenopausal osteoporosis
por: Wang, Qingchan, et al.
Publicado: (2022) -
Network pharmacology and molecular docking approach to elucidate the mechanisms of Liuwei Dihuang pill in diabetic osteoporosis
por: Lu, Zhaoqi, et al.
Publicado: (2022) -
Study on the Mechanism of Liuwei Dihuang Pills in Treating Parkinson's Disease Based on Network Pharmacology
por: Lin, Dongtao, et al.
Publicado: (2021) -
A network pharmacological-based study of the mechanism of Liuwei Dihuang pill in the treatment of chronic kidney disease
por: Xie, Xi, et al.
Publicado: (2023)